Erchonia Corporation has once again set the bar high in the field of medical innovation with its latest lineup of handheld devices.
This trio of groundbreaking products – each a marvel of engineering and design – offers unparalleled precision and effectiveness in laser therapy. From pain relief to accelerated healing, these devices embody Erchonia’s commitment to non-invasive, drug-free solutions.
With their sleek, user-friendly design and cutting-edge technology, these lasers are not just tools for healthcare professionals; they’re a testament to the power of light in transforming health and wellness. Experience the future of medical treatment with Erchonia’s latest laser devices – where science meets simplicity, and healing becomes an art.
The revolutionary XLR8 handheld laser therapy device. This dual-diode laser features an easy-to-operate graphical user interface (GUI), with a sleek new cord-free design.
With user definable channels and preset protocols, cold laser has become more flexible than ever before. This is our most popular entry-level laser — New to cold laser therapy? Then the handheld XLR8 is the laser for you!
The EVL laser system is designed with both red and violet lasers to offer varying wavelengths for a greater range of treatment options within one device. The red laser is appreciated for its superb healing qualities, while the violet laser provides anti-bacterial and anti-microbial properties.
Together, the two lasers allow veterinarians to safely and effectively treat an exceptional range of conditions.
We are excited to bring you the latest advancement in laser technology through rigorous clinical research and engineering. The GVL was shown to be the most effective wavelength combination for the increase of ROM and decrease in pain in a single session.
This is currently the first and only green wavelength laser FDA cleared for pain and inflammation. Unique to the green wavelength is the ability to affect complex 3 in the Electron Transport Chain (ETC). No other wavelength can impact this complex, and it is critical for moving to complex 4 to produce ATP.
Erchonia Corporation was founded in 1996 as a small family business, and even though we’ve grown into an international enterprise, we still operate under the founding principles that guided us to our present success.
Our commitment to the legitimate advancement of Low Level Laser Therapy (3LT®) through scientific and clinical research has transformed Erchonia into a world leader in the field of LLLT technology.
The integrity, diligence, quality and commitment of our company are evident in the rigorous process we follow in order to take a research hypothesis from concept to viable, agency-approved product and treatment method. To ensure a steadfast adherence to our unique all-encompassing approach, our company serves as
Follow on the periodontal, trials, and laser dental treatments.